Akebia Therapeutics (AKBA) Total Debt Growth (1y) (2019 - 2026)
Akebia Therapeutics (AKBA) Total Debt Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -0.14% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 37.52% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -92.65% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -9.19% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.63% |
| 10 | Akebia Therapeutics | 243.23 Mn | 80.63 Mn | 41.25 Mn | 5.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.11% |
| Dec 31, 2025 | 24.70% |
| Sep 30, 2025 | 24.21% |
| Jun 30, 2025 | 23.75% |
| Mar 31, 2025 | 54.29% |
| Dec 31, 2024 | 11.56% |
| Sep 30, 2024 | -9.99% |
| Jun 30, 2024 | -10.49% |
| Mar 31, 2024 | -40.06% |
| Dec 31, 2023 | -47.51% |
| Sep 30, 2023 | -35.38% |
| Jun 30, 2023 | -56.72% |
| Mar 31, 2023 | -48.60% |
| Dec 31, 2022 | -32.26% |
| Sep 30, 2022 | -32.17% |
| Jun 30, 2022 | 1.28% |
| Mar 31, 2022 | 1.28% |
| Dec 31, 2021 | 1.21% |
| Sep 30, 2021 | 26.92% |
| Jun 30, 2021 | 26.96% |